UONDDL
University of Notre Dame du Lac Portfolio holdings
AUM
$66.8M
This Quarter Return
-15.68%
1 Year Return
+43.52%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$324M
AUM Growth
+$324M
(+2.6%)
Cap. Flow
+$63.1M
Cap. Flow
% of AUM
19.45%
Top 10 Holdings %
Top 10 Hldgs %
44.08%
Holding
64
New
13
Increased
29
Reduced
13
Closed
8
Top Buys
| 1 |
Netflix
NFLX
|
$18.9M |
| 2 |
Charter Communications
CHTR
|
$12.9M |
| 3 |
Brookfield
BN
|
$11.8M |
| 4 |
Trupanion
TRUP
|
$8.54M |
| 5 |
Bank of New York Mellon
BK
|
$7.2M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$14.1M |
| 2 |
Tyler Technologies
TYL
|
$8.52M |
| 3 |
LPL Financial
LPLA
|
$8.23M |
| 4 |
Deere & Co
DE
|
$7.92M |
| 5 |
Crown Holdings
CCK
|
$7.76M |
Sector Composition
| 1 | Financials | 27.57% |
| 2 | Communication Services | 21.17% |
| 3 | Technology | 17.25% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zimmer Biomet
ZBH
$20.8B
| $6.27M | 1.93% |
+63,872
| New | +$6.27M |
|
27
Arch Capital
ACGL
$34.7B
| $5.93M | 1.83% |
208,316
+11,005
| +6% | +$313K |
|
28
KKR & Co
KKR
$120B
| $5.63M | 1.73% |
+239,693
| New | +$5.63M |
|
29
Equitable Holdings
EQH
$15.8B
| $5.52M | 1.7% |
381,857
+39,540
| +12% | +$571K |
|
|
CSOD
30
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $5.48M | 1.69% |
172,623
+34,774
| +25% | +$1.1M |
|
31
Meta Platforms (Facebook)
META
$1.85T
| $5.26M | 1.62% |
31,538
-9,939
| -24% | -$1.66M |
|
|
RDFN
32
DELISTED
Redfin
RDFN
| $5.06M | 1.56% |
+327,869
| New | +$5.06M |
|
33
Salesforce
CRM
$245B
| $4.73M | 1.46% |
+32,817
| New | +$4.73M |
|
34
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $3.57M | 1.1% |
106,391
+181
| +0.2% | +$6.07K |
|
35
Garrett Motion
GTX
$2.61B
| $3.47M | 1.07% |
1,214,162
+430,110
| +55% | +$1.23M |
|
|
IGMS
36
DELISTED
IGM Biosciences
IGMS
| $1.43M | 0.44% |
25,394
-10,134
| -29% | -$569K |
|
|
GPOR
37
DELISTED
Gulfport Energy Corp.
GPOR
| $1.22M | 0.38% |
2,736,392
+182,292
| +7% | +$81.1K |
|
|
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.07M | 0.33% |
9,300
+864
| +10% | +$99.7K |
|
39
BioMarin Pharmaceuticals
BMRN
$11.3B
| $1.04M | 0.32% |
12,336
-309
| -2% | -$26.1K |
|
40
Incyte
INCY
$17B
| $1.03M | 0.32% |
13,997
+2,857
| +26% | +$209K |
|
|
PRNB
41
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.01M | 0.31% |
+16,982
| New | +$1.01M |
|
42
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.01M | 0.31% |
23,824
+2,806
| +13% | +$119K |
|
|
ALXN
43
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $961K | 0.3% |
10,706
+1,681
| +19% | +$151K |
|
|
MRTX
44
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $916K | 0.28% |
11,913
+2,650
| +29% | +$204K |
|
45
Neurocrine Biosciences
NBIX
$13.5B
| $911K | 0.28% |
10,527
+1,829
| +21% | +$158K |
|
46
argenx
ARGX
$44.2B
| $903K | 0.28% |
6,854
-102
| -1% | -$13.4K |
|
47
Ascendis Pharma
ASND
$12.1B
| $877K | 0.27% |
7,787
-776
| -9% | -$87.4K |
|
48
Kodiak Sciences
KOD
$453M
| $873K | 0.27% |
18,301
-19,897
| -52% | -$949K |
|
49
Madrigal Pharmaceuticals
MDGL
$9.7B
| $812K | 0.25% |
12,169
+2,491
| +26% | +$166K |
|
50
Zymeworks
ZYME
$1.07B
| $812K | 0.25% |
+22,890
| New | +$812K |
|